Hypocalcemia

Hypocalcemia is a metabolic disorder characterized by a decrease in the concentration of ionized calcium (iCa) in the blood below the reference range, typically defined as total serum calcium < 8.5 mg/dL (2.1 mmol/L) in dogs and < 7.5 mg/dL (1.9 mmol/L) in cats, or ionized calcium < 1.0 mmol/L in dogs and < 0.9 mmol/L in cats. Calcium is essential for numerous physiological processes, including neuronal excitability, muscle contraction, blood coagulation, enzyme function, and cell signaling. Hypocalcemia can be classified based on severity (mild, moderate, severe), chronicity (acute vs. chronic), and underlying cause (e.g., hypoparathyroidism, renal failure, pancreatitis, eclampsia). Clinical manifestations range from subclinical to life-threatening, with severe hypocalcemia leading to tetany, seizures, and cardiac arrhythmias. Prompt recognition and treatment are critical to prevent morbidity and mortality.

The etiologies of hypocalcemia are diverse and can be categorized into disorders of parathyroid hormone (PTH) secretion or action, vitamin D metabolism, calcium sequestration, and iatrogenic causes. Primary hypoparathyroidism, often immune-mediated or idiopathic, results in deficient PTH secretion. Secondary hypoparathyroidism can occur due to thyroidectomy (iatrogenic), parathyroid gland destruction (e.g., granulomatous disease, neoplasia), or magnesium depletion (which impairs PTH secretion and action). Vitamin D deficiency or resistance, due to inadequate dietary intake, malabsorption, chronic renal failure (decreased renal 1-alpha-hydroxylase activity), or certain drugs (e.g., phenobarbital, which induces hepatic catabolism of vitamin D), leads to decreased intestinal calcium absorption. Acute pancreatitis causes hypocalcemia via saponification of peripancreatic fat and increased calcitonin release. Eclampsia (puerperal tetany) occurs in lactating bitches and queens due to excessive calcium loss in milk. Chronic renal failure leads to hyperphosphatemia, decreased renal production of calcitriol, and calcium-phosphate precipitation. Other causes include ethylene glycol toxicity (calcium oxalate precipitation), tumor lysis syndrome, massive blood transfusion (citrate chelation), and hypomagnesemia. Rarely, nutritional secondary hyperparathyroidism (e.g., all-meat diets) can cause hypocalcemia due to high phosphorus and low calcium intake.

Hypocalcemia is a relatively common electrolyte disorder in small animal practice, with prevalence varying by underlying cause. Primary hypoparathyroidism is uncommon, with a higher incidence in certain breeds, including Toy Poodles, Miniature Schnauzers, and Labrador Retrievers, and typically affects middle-aged to older dogs. Eclampsia is most common in small-breed dogs (e.g., Chihuahuas, Pomeranians) and cats, usually occurring within 1-4 weeks postpartum. Chronic kidney disease (CKD) is a common cause of hypocalcemia in older dogs and cats, with prevalence increasing with disease severity. Acute pancreatitis is more frequent in dogs, particularly in Miniature Schnauzers and other breeds predisposed to hyperlipidemia. Hypocalcemia secondary to hypomagnesemia is often seen in critically ill patients, especially those with gastrointestinal disease or sepsis. There is no strong sex predilection, though eclampsia is exclusive to females. Geographic variation may reflect dietary practices and prevalence of underlying diseases.

Calcium homeostasis is tightly regulated by PTH, calcitriol (1,25-dihydroxyvitamin D), and calcitonin. PTH increases serum calcium by stimulating bone resorption, renal tubular reabsorption of calcium, and renal production of calcitriol. Calcitriol enhances intestinal calcium absorption and mobilizes calcium from bone. Calcitonin lowers calcium by inhibiting osteoclast activity. Hypocalcemia arises when these regulatory mechanisms fail or when calcium is excessively lost or sequestered. In primary hypoparathyroidism, deficient PTH leads to decreased bone resorption, reduced renal calcium reabsorption, and decreased calcitriol synthesis, resulting in hypocalcemia and hyperphosphatemia. In CKD, hyperphosphatemia and decreased calcitriol production impair calcium absorption and promote calcium-phosphate precipitation. Acute pancreatitis causes calcium sequestration in saponified fat and increased calcitonin release. Eclampsia results from rapid calcium loss into milk, overwhelming compensatory mechanisms. Hypomagnesemia impairs PTH secretion and end-organ responsiveness. The clinical signs of hypocalcemia are primarily due to increased neuronal excitability, as calcium is required for stabilization of the neuronal membrane and regulation of neurotransmitter release. Reduced extracellular calcium increases sodium permeability, leading to spontaneous depolarization and tetany. Severe hypocalcemia can also affect cardiac muscle, causing arrhythmias and decreased contractility.

Predisposing factors for hypocalcemia include breed and genetic predisposition (e.g., Toy Poodles for primary hypoparathyroidism, Miniature Schnauzers for pancreatitis), age (eclampsia in young lactating females, CKD in geriatric patients), sex (eclampsia in females), and concurrent diseases (e.g., CKD, pancreatitis, hypomagnesemia, sepsis). Iatrogenic factors include thyroidectomy or parathyroidectomy, use of drugs that lower calcium (e.g., bisphosphonates, calcitonin, loop diuretics, corticosteroids), and massive blood transfusions with citrate anticoagulant. Nutritional factors include diets with low calcium-to-phosphorus ratio, vitamin D deficiency, or excessive phosphorus intake. Management factors include inadequate monitoring of calcium levels in postoperative patients or those on long-term anticonvulsant therapy. Environmental factors such as exposure to ethylene glycol (antifreeze) can cause hypocalcemia due to calcium oxalate precipitation.

Clinical signs of hypocalcemia vary with severity and rate of onset. Mild hypocalcemia (total calcium 7.5-8.5 mg/dL in dogs) may be asymptomatic. Moderate to severe hypocalcemia (<7.5 mg/dL) typically manifests with neuromuscular signs. Peracute and acute signs include muscle tremors, fasciculations, twitching, stiff gait, ataxia, and behavioral changes (restlessness, anxiety, aggression). As hypocalcemia worsens, tetany, carpal or pedal spasms, and seizures may occur. Cats may exhibit panting, hypersalivation, and vocalization. Chronic hypocalcemia can cause cataracts, cardiac arrhythmias (e.g., QT prolongation, ventricular tachycardia), and congestive heart failure. Physical examination may reveal hyperthermia due to muscle activity, tachycardia or bradycardia, and arrhythmias. In eclampsia, signs typically appear 1-4 weeks postpartum and include restlessness, panting, tremors, and progression to tetany and seizures. In CKD, signs are often overshadowed by uremia (anorexia, vomiting, lethargy).

Differential diagnoses for hypocalcemia include: 1) Primary hypoparathyroidism: distinguished by low PTH levels, hyperphosphatemia, and normal renal function. 2) Chronic kidney disease: characterized by azotemia, hyperphosphatemia, and decreased urine concentrating ability. 3) Acute pancreatitis: presents with vomiting, abdominal pain, and elevated lipase/PLI. 4) Eclampsia: occurs in lactating females, with rapid onset of tremors and tetany. 5) Hypomagnesemia: often coexists with hypocalcemia; magnesium levels are low. 6) Vitamin D deficiency or resistance: may be due to dietary deficiency, malabsorption, or drug-induced; 25-hydroxyvitamin D levels are low. 7) Ethylene glycol toxicity: history of exposure, metabolic acidosis, oxalate crystalluria. 8) Tumor lysis syndrome: occurs after chemotherapy in patients with large tumor burden; hyperphosphatemia and hyperkalemia are also present. 9) Massive blood transfusion: history of recent transfusion, citrate toxicity. 10) Nutritional secondary hyperparathyroidism: dietary history of all-meat diet, high phosphorus, low calcium.

The diagnostic approach to hypocalcemia should be systematic. Step 1: Confirm hypocalcemia with total and ionized calcium measurements. Ionized calcium is the physiologically active form and is preferred for diagnosis. Step 2: Perform a thorough history and physical examination, focusing on postpartum status, dietary history, drug exposure, and signs of renal or pancreatic disease. Step 3: Obtain a minimum database including CBC, serum biochemistry (including albumin, phosphorus, magnesium, creatinine, BUN, lipase, and amylase), and urinalysis. Correct total calcium for albumin if ionized calcium is unavailable: corrected calcium (mg/dL) = measured total calcium - albumin (g/dL) + 3.5 (dogs) or + 3.0 (cats). Step 4: Measure serum PTH concentration. Low PTH in the face of hypocalcemia indicates primary hypoparathyroidism. High PTH suggests secondary causes (e.g., CKD, vitamin D deficiency). Step 5: Measure serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels if vitamin D disorders are suspected. Step 6: Evaluate for specific causes: abdominal ultrasound for pancreatitis, renal ultrasound for CKD, and blood gas for ethylene glycol toxicity. Step 7: Consider additional tests such as magnesium, cardiac troponin, and electrocardiography if arrhythmias are present. Step 8: In cases of suspected eclampsia, response to calcium supplementation is diagnostic.

Hematology: CBC may be normal or show stress leukogram. Serum biochemistry: Total calcium is decreased; ionized calcium is decreased. Albumin may be low (if hypoalbuminemia is present, corrected calcium should be calculated). Phosphorus is typically elevated in hypoparathyroidism and CKD, but may be normal or low in pancreatitis. Magnesium may be low. Creatinine and BUN are elevated in CKD. Lipase and pancreatic lipase immunoreactivity (PLI) are elevated in pancreatitis. Urinalysis: In CKD, urine specific gravity is low (<1.030 in dogs, <1.035 in cats), and proteinuria may be present. In ethylene glycol toxicity, calcium oxalate crystalluria and isosthenuria are seen. Blood gas analysis: Metabolic acidosis may be present in ethylene glycol toxicity or CKD. Specific biomarkers: PTH is low in primary hypoparathyroidism and high in secondary causes. 25-hydroxyvitamin D is low in vitamin D deficiency. Parathyroid hormone-related peptide (PTHrP) may be elevated in humoral hypercalcemia of malignancy (but this causes hypercalcemia, not hypocalcemia). Cardiac troponin I may be elevated if myocardial damage occurs. Electrocardiography may show prolonged QT interval, ST segment changes, and ventricular arrhythmias.

Radiography: Thoracic radiographs may reveal cardiomegaly or pulmonary edema in cases of heart failure secondary to chronic hypocalcemia. Abdominal radiographs may show evidence of pancreatitis (loss of detail, mass effect) or renal mineralization. Ultrasonography: Abdominal ultrasound is useful for evaluating the pancreas (enlarged, hypoechoic, peripancreatic fluid in pancreatitis) and kidneys (small, irregular, increased echogenicity in CKD). Parathyroid gland ultrasound may identify neoplasia or hyperplasia. Echocardiography: May be indicated if cardiac arrhythmias or heart failure are suspected. Computed tomography (CT) or magnetic resonance imaging (MRI) are rarely needed but may be used to evaluate the parathyroid glands or brain if seizures are refractory. Endoscopy is not typically used for hypocalcemia diagnosis.

Cytology and histopathology are not routinely used for the diagnosis of hypocalcemia itself, but may be helpful in identifying underlying causes. Fine needle aspirate of the parathyroid gland may reveal adenoma or carcinoma. Histopathology of the parathyroid gland (if surgically removed) can confirm primary hypoparathyroidism (lymphocytic infiltration, atrophy). Renal biopsy may be performed in CKD to determine the underlying etiology. Pancreatic biopsy may be considered in chronic pancreatitis. These procedures are generally reserved for cases where the diagnosis is uncertain or when surgical intervention is planned.

Treatment of hypocalcemia depends on the severity and underlying cause. Emergency treatment for severe hypocalcemia (ionized calcium <0.7 mmol/L or clinical signs) involves intravenous calcium gluconate 10% solution at a dose of 0.5-1.5 mL/kg (50-150 mg/kg) over 10-20 minutes with electrocardiographic monitoring. This is followed by a continuous rate infusion (CRI) of calcium gluconate at 5-15 mg/kg/hour (0.5-1.5 mL/kg/hour of 10% solution) in 0.9% saline, titrated to maintain ionized calcium within the low-normal range. Once stabilized, oral calcium supplementation (calcium carbonate or calcium citrate) is initiated at 25-50 mg/kg/day divided q8h. Vitamin D supplementation is required for primary hypoparathyroidism: calcitriol (0.02-0.03 µg/kg/day PO) is preferred due to its rapid onset and short half-life; alternatively, dihydrotachysterol (0.02 mg/kg/day PO) or ergocalciferol (1000-2000 IU/kg/day PO) can be used. For eclampsia, puppies/kittens should be removed from the dam and fed a milk replacer; the dam receives calcium supplementation and supportive care. For CKD, treatment includes dietary phosphorus restriction, phosphate binders (e.g., aluminum hydroxide 30-100 mg/kg/day PO), and calcitriol if indicated. For pancreatitis, supportive care with IV fluids, analgesics, and antiemetics is essential. Hypomagnesemia should be corrected with magnesium sulfate (0.75-1 mEq/kg/day IV CRI). Underlying causes (e.g., ethylene glycol toxicity) require specific therapy (e.g., ethanol or fomepizole).

Prognosis depends on the underlying cause and severity. For primary hypoparathyroidism, with appropriate long-term calcium and vitamin D supplementation, the prognosis is good, though lifelong therapy is required. Eclampsia has an excellent prognosis with prompt treatment, and recurrence is possible in subsequent litters. Hypocalcemia secondary to CKD carries a guarded prognosis, as it indicates advanced renal disease. Pancreatitis-associated hypocalcemia is a negative prognostic indicator, with increased mortality. Iatrogenic hypocalcemia (e.g., post-thyroidectomy) is usually transient and has a good prognosis if managed appropriately. Severe hypocalcemia with seizures or cardiac arrhythmias can be fatal if untreated. Overall, early recognition and aggressive management improve outcomes.

Follow-up is essential to monitor response to therapy and adjust medications. Initially, ionized calcium should be measured every 6-12 hours during the acute phase. Once stable, total calcium and phosphorus should be checked weekly for the first month, then monthly for 3 months, and then every 3-6 months. For primary hypoparathyroidism, the goal is to maintain total calcium in the low-normal range (8.5-9.5 mg/dL) to avoid hypercalciuria and nephrocalcinosis. Vitamin D and calcium doses should be adjusted based on calcium levels. For CKD, regular monitoring of renal parameters (creatinine, SDMA, phosphorus, UPC) and blood pressure is recommended. For eclampsia, the dam should be monitored for recurrence, and future litters may require prophylactic calcium supplementation. Owners should be educated on signs of hypocalcemia and when to seek emergency care.

Pearls: 1) Always measure ionized calcium, as total calcium can be falsely low with hypoalbuminemia. 2) In hypocalcemic patients, check magnesium levels; hypomagnesemia can cause refractory hypocalcemia. 3) In lactating animals with tremors, eclampsia is a top differential; response to calcium is diagnostic. 4) When treating with IV calcium, monitor ECG for bradycardia or arrhythmias; slow the infusion if heart rate decreases. 5) For long-term management of hypoparathyroidism, calcitriol is preferred over ergocalciferol due to better control. Pitfalls: 1) Administering IV calcium too rapidly can cause cardiac arrest. 2) Using calcium gluconate instead of calcium chloride to avoid tissue necrosis if extravasation occurs. 3) Failing to correct hypomagnesemia, which can lead to persistent hypocalcemia. 4) Over-supplementing vitamin D, causing hypercalcemia and renal damage. 5) Not considering underlying causes such as ethylene glycol toxicity, which requires specific antidote.

Based on Plumb's Veterinary Drug Handbook, the following protocols are recommended: 1) Calcium gluconate 10% solution: For emergency treatment, 0.5-1.5 mL/kg IV over 10-20 minutes, with ECG monitoring. For CRI, 5-15 mg/kg/hour (0.5-1.5 mL/kg/hour) in 0.9% saline. 2) Calcium carbonate: Oral, 25-50 mg/kg/day divided q8h, with food. 3) Calcitriol: Oral, 0.02-0.03 µg/kg/day, initially, then adjust based on calcium levels. 4) Dihydrotachysterol: Oral, 0.02 mg/kg/day, then 0.01 mg/kg/day as maintenance. 5) Ergocalciferol (vitamin D2): Oral, 1000-2000 IU/kg/day, with a loading dose of 4000-6000 IU/kg/day for 1-2 weeks. 6) Magnesium sulfate: For hypomagnesemia, 0.75-1 mEq/kg/day IV CRI, or 0.15-0.3 mEq/kg IV over 5-15 minutes. 7) Aluminum hydroxide: Oral, 30-100 mg/kg/day divided with meals, as a phosphate binder. 8) For pancreatitis: IV fluids (e.g., lactated Ringer's solution at 60-100 mL/kg/day), analgesics (e.g., buprenorphine 0.01-0.02 mg/kg IV q8-12h), antiemetics (e.g., maropitant 1 mg/kg SC q24h). 9) For ethylene glycol toxicity: Fomepizole (dogs) 20 mg/kg IV initially, then 15 mg/kg at 12 and 24 hours, then 5 mg/kg at 36 hours; or ethanol (dogs and cats) 5.5 mL/kg of 20% solution IV q6h for 5 treatments, then q8h for 4 treatments. Dosages should be adjusted for renal or hepatic impairment, and drug interactions should be considered (e.g., calcium with digoxin increases toxicity).

Key studies and consensus guidelines: 1) ACVIM consensus statement on hypocalcemia in dogs and cats (2016) emphasizes the importance of ionized calcium measurement and provides treatment algorithms. 2) A study by Chew et al. (2011) on primary hypoparathyroidism in dogs reported successful long-term management with calcitriol and calcium supplementation. 3) Research on eclampsia in bitches (e.g., Feldman and Nelson, 2004) highlights the need for prompt calcium administration and supportive care. 4) Studies on CKD (IRIS guidelines) recommend monitoring ionized calcium and using calcitriol in select cases. 5) A meta-analysis on pancreatitis in dogs (e.g., Mansfield et al., 2012) identified hypocalcemia as a negative prognostic indicator. 6) Evidence-based reviews on magnesium disorders (e.g., Dhupa and Proulx, 1998) support routine magnesium measurement in hypocalcemic patients. 7) Clinical trials on ethylene glycol toxicity (e.g., Connally et al., 1996) demonstrate the efficacy of fomepizole in dogs. These sources provide the foundation for current diagnostic and therapeutic recommendations.